Drug ID: | NPD3018 |
Drug Name: | OXI-4503 |
Molecular Formula: | C18H22O12P2 |
Canonical SMILES: | COc1cc(/C=Cc2ccc(c(c2OP(=O)(O)O)OP(=O)(O)O)OC)cc(c1OC)OC |
Standard InCHI: | InChI=1S/C18H22O12P2/c1-25-13-8-7-12(16(29-31(19,20)21)18(13)30-32(22,23)24)6-5-11-9-14(26-2)17(28-4)15(10-11)27-3/h5-10H,1-4H3,(H2,19,20,21)(H2,22,23,24)/b6-5- |
Standard InCHIKey: | GSOXMQLWUDQTNT-WAYWQWQTSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | DrugBank |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002273 |
DrugBank | DB05143 |
ChEMBL | CHEMBL1205402 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 56841628 |
ChEBI | |
CAS Number | 288847-35-8 |
Molecular Weight | 492.06 |
ALogP | -0.5316 |
MLogP | 1.9 |
XLogP | -0.257 |
HDA | 6 |
HBD | 4 |
Rotatable Bonds | 18 |
TPSA | 190.06 |
RO5 Violation | 0 |